Peptides AcademyPT-141 + Kisspeptin-10 Sexual Health Stack
PT-141 and Kisspeptin-10 target complementary aspects of sexual function — central desire pathways and upstream hormonal regulation respectively. PT-141 activates melanocortin-4 receptors for acute libido enhancement while Kisspeptin-10 stimulates GnRH release, which drives testosterone and estrogen production. The combination addresses both the motivational and hormonal dimensions of sexual health.
Quick Comparison
| Property | peptide | The Sexual Health Stack: PT-141 + Kisspeptin-10 |
|---|---|---|
| Source | Salmon DNA fragments | Various sources |
| Primary Mechanism | A2A receptor activation, DNA repair | Varies by ingredient |
| Key Benefits | Tissue regeneration, anti-inflammation, collagen boost | Multiple skin benefits |
| Best Time to Apply | AM or PM | AM or PM |
| Can Combine? | Generally compatible — check specific guidelines. | |
How to Use Together
PT-141 (bremelanotide) is used as-needed at 0.5–2 mg subcutaneously, 45–60 minutes before anticipated sexual activity. Maximum 8 doses per month. Kisspeptin-10 is research-grade with no established clinical protocol — preclinical dosing ranges from 0.1–1 nmol/kg IV in human studies assessing LH response. The two address different timescales: PT-141 for acute desire enhancement, Kisspeptin for underlying hormonal support.
Safety Notes
PT-141 can cause transient blood pressure elevation and nausea (approximately 40% of users). Not recommended for individuals with uncontrolled hypertension or cardiovascular disease. Kisspeptin-10 is an early-stage research peptide with limited human safety data beyond single-dose pharmacology studies. Both should be used under medical supervision.
Recommended Products (2)
Kisspeptin-10
Research-Grade
A 10-amino-acid fragment of the endogenous kisspeptin neuropeptide that activates GnRH neurons — the master switch of the reproductive hormone axis — studied for infertility, metabolic health, and diagnostic endocrinology.
PT-141 (Bremelanotide)
Vyleesi
A melanocortin receptor agonist FDA-approved for hypoactive sexual desire disorder in premenopausal women, acting on central nervous-system pathways rather than vascular ones.
Frequently Asked Questions
Does this stack work for both men and women?
How does PT-141 differ from Viagra/Cialis?
Is Kisspeptin-10 clinically validated?
Other peptide Ingredient Combinations
The Anti-Aging Stack: GHK-Cu + Epitalon
GHK-Cu and Epitalon target two distinct hallmarks of aging — extracellular matrix degradation and te…
The Cognitive Stack: Semax + Selank
The classic Russian nootropic peptide pairing. Semax (an ACTH 4-10 analog) enhances BDNF expression …
The Fat Loss Stack: Tesamorelin + CJC-1295/Ipamorelin
Tesamorelin and CJC-1295/Ipamorelin both target the GH axis but through complementary timing and rec…
The GH Stack: CJC-1295 + Ipamorelin
The dual-pathway growth-hormone stack. CJC-1295 (GHRH analog) opens the pituitary somatotroph; Ipamo…
The Healing Stack: BPC-157 + TB-500
The canonical regenerative-peptide pairing. BPC-157 and TB-500 operate through non-overlapping biolo…
Immune Support Stack
A combination approach targeting immune function through three complementary mechanisms: adaptive im…
The Longevity Stack: Epitalon + MOTS-c + SS-31
Three peptides targeting different hallmarks of aging: Epitalon for telomerase activation and pineal…
The Metabolic Stack: GLP-1 + GHS
A newer 'metabolic recomposition' pairing some practitioners use: a GLP-1 agonist for appetite and t…
The Sleep Stack: DSIP + Ipamorelin
DSIP (Delta Sleep-Inducing Peptide) and ipamorelin target complementary aspects of sleep optimizatio…